The $23 Billion Bet
How Novartis Is Building the Future of U.S. Healthcare
Pharma giant Novartis just announced a major move: it plans to invest $23 billion into its U.S. operations over the next five years. The focus? Expanding manufacturing capacity and strengthening research and development (R&D) across key regions. This isn’t just a win for the company—it’s a strategic decision that speaks volumes about the direction of he…
Keep reading with a 7-day free trial
Subscribe to Everyday.MBA to keep reading this post and get 7 days of free access to the full post archives.